Watch, LLC, the IV safety company, today announced it has submitted a 510(k) filing to the U.S. Food and Drug Administration (FDA) for its SmartTouch+™ Sensor, expanding the company's IV monitoring ...
Disruptive innovation provides NHS Trusts faster access to continuous IV monitoring to reduce avoidable extravasation harm NEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch, the IV ...
Hampton Roads-based medical device company ivWatch, LLC racked up several prestigious recognitions and awards this year for its innovative work in enhancing IV safety. The company, headquartered in ...
The necessity for routine replacement of an IV peripheral cannula to prevent bacteremia was evaluated in a high-quality randomized trial. Patients older than 18 years (N = 755) without current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results